President Donald Trump’s trade tariffs on Canadian pharmaceuticals are expected to increase costs in the United States and ...
Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...
Novo Nordisk has defended disappointing trial results for its much-hyped next generation obesity drug candidate CagriSema, ...
The impact be especially strong on users of some formulations of testosterone, an antidepressant and an anti-brain-bleed drug ...
The maker of a new prescription drug product for people with life-threatening allergies is using copayment coupons to build ...
Up to $3 billion in pharmaceuticals currently used in the United States (U.S.) depend on Canadian manufacturing, according to ...
Novo Nordisk is licensing Lexicon Pharmaceuticals' experimental obesity drug in a deal worth up to $1 billion, the Danish ...
Public advisory - Unauthorized injectable peptide drugs seized from Optimum Wellness Centre in Calgary, Alberta may pose serious health risks ...
The Department of Pharmaceuticals aims to enhance access to affordable treatments for cancer and other critical illnesses.
With over 15 years of expertise in developing injectable and liquid pharmaceutical forms, CARBOGEN AMCIS' Saint-Beauzire site ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback